Abstract:Ligand-sensitized, luminescent lanthanide(III) complexes are of considerable importance because their unique photophysical properties (microsecond to millisecond lifetimes, characteristic and narrow emission bands, and large Stokes shifts) make them well suited as labels in fluorescence-based bioassays. The long-lived emission of lanthanide(III) cations can be temporally resolved from scattered light and background fluorescence to vastly enhance measurement sensitivity. One challenge in this field is the design of sensitizing ligands that provide highly emissive complexes with sufficient stability and aqueous solubility for practical applications. In this Account, we give an overview of some of the general properties of the trivalent lanthanides and follow with a summary of advances made in our laboratory in the development of highly luminescent Tb(III) and Eu(III) complexes for applications in biotechnology. A focus of our research has been the optimization of these compounds as potential commercial agents for use in homogeneous time-resolved fluorescence (HTRF) technology. Our approach involves developing high-stability octadentate Tb(III) and Eu(III) complexes that rely on all-oxygen donor atoms and using multichromophore chelates to increase molar absorptivity; earlier examples utilized a single pendant chromophore (that is, a single "antenna"). Ligands based on 2-hydroxyisophthalamide (IAM) provide exceptionally emissive Tb(III) complexes with quantum yield values up to approximately 60% that are stable at the nanomolar concentrations required for commercial assays. Through synthetic modification of the IAM chromophore and time-dependent density functional theory (TD-DFT) calculations, we have developed a method to predict absorption and emission properties of these chromophores as a tool to guide ligand design. Additionally, we have investigated chiral IAM ligands that yield Tb(III) complexes possessing both high quantum yield values and strong circularly polarized luminescence (CPL) activity. To efficiently sensitize Eu(III) emission, we have used the 1-hydroxypyridin-2-one (1,2-HOPO) chelate to create remarkable ligands that combine excellent photophysical properties and exceptional aqueous stabilities. A more complete understanding of this chromophore has been achieved by combining low-temperature phosphorescence measurements with the same TD-DFT approach used with the IAM system. Eu(III) complexes with strong CPL activity have also been obtained with chiral 1,2-HOPO ligands. We have also undertaken kinetic analysis of radiative and nonradiative decay pathways for a series of Eu(III) complexes; the importance of the metal ion symmetry on the ensuing photophysical properties is clear. Lastly, we describe a Tb(III)-IAM compound--now carried through to commercial availability--that offers improved performance in the common HTRF platform and has the potential to vastly improve sensitivity.

7-Amino Actinomycin D Bound to Single-Stranded Hairpin DNA Enhanced by Loop Sequence-Dependent Luminescent Eu(3+) and Tb(3+) Binding.

Luminescent lanthanide(III) complexes of DTPA-bis(amido-phenyl-terpyridine) for bioimaging and phototherapeutic applications

Crystal structure of actinomycin D bound to the CTG triplet repeat sequences linked to neurological diseases

Ln(III) Chelates-Functionalized Carbon Quantum Dots: Synthesis, Optical Studies and Multimodal Bioimaging Applications.

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Lanthanide spectroscopic studies of the dinuclear and Mg(II)-dependent PvuII restriction endonuclease

Fluorescent Bioprobes: Structural Matching in the Docking Processes of Aggregation-Induced Emission Fluorogens on DNA Surfaces.

From antenna to assay: lessons learned in lanthanide luminescence

Structure–affinity relationships for the binding of actinomycin D to DNA

Molecular Recognition of Parallel G-quadruplex [d-(TTGGGGT)]4 Containing Tetrahymena Telomeric DNA Sequence by Anticancer Drug Daunomycin: NMR-Based Structure and Thermal Stability

Luminescent Dimeric Oxalate-Bridged Eu3+/Tb3+-Implanted Arsenotungstates: Tunable Emission, Energy Transfer, and Detection of Ba2+ Ion in Aqueous Solution

Conditionally Designed Luminescent DNA Crystals Doped by Ln3+(Eu3+/Tb3+) Complexes or Fluorescent Proteins with Smart Drug Sensing Property

Fabrication of a series of isostructural water-stable lanthanide metal-organic frameworks: Tunable luminescence, sensing for antibiotics and magnetic properties

Structure regulation for ultra-high luminescence quantum yield lanthanide complex and simultaneous detection of cancer marker and ferrous ion

Probing Metal Binding in the 8-17 DNAzyme by TbIII Luminescence Spectroscopy.

Cationic lanthanide luminescent copolymer: Design, synthesis and interaction with DNA

Structure and spectral performance of Co(II) and Co(III) complexes for DNA-binding: Synthesis, characterization and comparison

Preparation, Characterization of Cationic Terbium Luminescent Copolymer and Its Interaction with Dna

Novel Eu(III) and Tb(III) complexes bearing carboxamide ligand: antiproliferative activity, photoluminescence properties, and thermogravimetric studies

Enhancing visual fluorescence detection of tetracycline antibiotics through nitrogen containing ligand regulation and antenna effect of Ln3+

Drug Effect of Thulium(III)-Arsenazo III Complex on Herring Sperm DNA